SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019247
Filing Date
2024-05-14
Accepted
2024-05-14 16:16:08
Documents
79
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 927979
2 ex31-1.htm EX-31.1 17596
3 ex31-2.htm EX-31.2 17587
4 ex32-1.htm EX-32.1 6713
5 ex32-2.htm EX-32.2 6695
  Complete submission text file 0001493152-24-019247.txt   5686263

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20240331.xsd EX-101.SCH 48619
7 XBRL CALCULATION FILE vvos-20240331_cal.xml EX-101.CAL 63889
8 XBRL DEFINITION FILE vvos-20240331_def.xml EX-101.DEF 190829
9 XBRL LABEL FILE vvos-20240331_lab.xml EX-101.LAB 362519
10 XBRL PRESENTATION FILE vvos-20240331_pre.xml EX-101.PRE 298703
82 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 824331
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39796 | Film No.: 24944580
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)